Shopping Cart
- Remove All
- Your shopping cart is currently empty
GPRC5D Protein, Human, Recombinant, Biotinylated is expressed in HEK293 mammalian cells. The predicted molecular weight is 38.80 kDa and the accession number is Q9NZD1-1.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
20 μg | $838 | 7-10 days | |
100 μg | $1,670 | 7-10 days | |
500 μg | $5,310 | 7-10 days |
Biological Activity | Immobilized Biotinylated Human GPRC5D-VLP (Full Length) Protein at 5 μg/mL (100 μL/well) on streptavidin precoated (2 μg/well) can bind Anti-Human GPRC5D Antibody, Human IgG1, the EC50 is 4-12ng/mL. |
Description | GPRC5D Protein, Human, Recombinant, Biotinylated is expressed in HEK293 mammalian cells. The predicted molecular weight is 38.80 kDa and the accession number is Q9NZD1-1. |
Species | Human |
Expression System | HEK293 Cells |
Tag | Tag Free |
Accession Number | Q9NZD1-1 |
Synonyms | GPRC5D |
Construction | A DNA sequence encoding the human GPRC5D (Q9NZD1-1) (Met1-Val345) was expressed. Predicted N terminal: Met 1 |
Molecular Weight | 38.80 kDa (predicted) |
Endotoxin | < 1.0 EU/μg of the protein as determined by the LAL method. |
Formulation | Supplied as sterile solution in 50 mM HEPES, 150 mM NaCI, 10% Trehalose, pH 7.2. |
Stability & Storage | It is recommended to store the product under sterile conditions at -70°C or lower. Samples are stable for up to 12 months at -80°C. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
Shipping | Shipping with blue ice. |
Research Background | Orphan G-protein-coupled receptor family C group 5 member D (GPRC5D) has seven transmembrane segments forming the core of the receptor, as well as an intracellular C-tail and an extracellular N-terminal domain. GPRC5D is highly and selectively expressed on the surface of CD138+ multiple myeloma (MM) cells, whereas in normal tissues, a much lower expression is limited to plasma cells and certain hard keratinizing tissues. This makes GPRC5D a promising marker for monitoring tumor load and a target antigen for MM-specific T cell-engaging therapies such as bispecific antibodies and CAR-T cells. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.